The Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease and a Review of the Pertinent Literature
Qian Zhang(Brigham and Women's Hospital), Xue Zhang(Fudan University), Peicong Ge(Capital Medical University), Xingju Liu(Capital Medical University), Xiaofeng Deng(Capital Medical University), Yuanli Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Rong Wang(Yinchuan First People's Hospital), Dong Zhang(Yangpu Hospital of Tongji University), Yan Zhang(Shenzhen Children's Hospital), Shuo Wang(Kailuan General Hospital), Ran Duan(Central South University), Yonggang Ma(Capital Medical University), Le‐Bao Yu(Baylor College of Medicine), Jizong Zhao(Capital Medical University), Yaping Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Yong Cao(Capital Medical University)
Cited by 25
Related Papers
Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential
|Journal of Neurology|2020|132
RNA-binding protein PCBP2 modulates glioma growth by regulating FHL3
|Journal of Clinical Investigation|2013|107
Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease
|Journal of neurosurgery|2018|105